文献速递围术期管理与 ERAS急腹症与外科感染

择期手术患者高危物质使用及多物质使用:患病率与危险因素

High-Risk Substance and Polysubstance Use Among Elective Surgery Patients: Prevalence and Risk Factors.
PubMed 文献 · J Am Coll Surg · 2026-05-01

该横断面分析基于2,688例21至75岁择期手术患者的术前筛查数据,发现27.6%报告高危物质使用,6.6%报告多物质使用,大麻最常见(15.0%),年轻、男性及自评健康较差与高危使用相关,不同外科服务患病率存在差异。

要点

  • 超过1/4择期手术患者术前存在高危物质使用,大麻最常见。
  • 年轻、男性及自评健康较差者高危物质使用风险更高。
  • 神经外科高危和多物质使用率最高,内分泌外科最低。

核心结论

  • 超过四分之一的择期手术患者术前报告高危物质使用,支持普遍术前筛查。

研究设计与样本

  • 横断面分析,纳入临床试验(NCT05783635)中2,688例21至75岁择期手术成人,完成酒精、尼古丁、大麻及其他药物使用的验证性自评量表。

主要发现

  • 27.6%(743例)报告高危物质使用,6.6%(177例)报告多物质使用。
  • 大麻高危使用最普遍(15.0%),其次为酒精(11.1%)、尼古丁(8.5%)及其他药物(0.4%)。
  • 年轻、男性及自评健康较差与高危使用风险增加相关。
  • 神经外科高危和多物质使用率最高(27.1%和11.4%),内分泌外科最低(15.1%和3.3%)。

关键数值与推荐

  • 高危使用定义为酒精使用障碍识别测试-消费版(AUDIT-C)得分≥5或每周/每日使用其他物质。
  • 多物质使用定义为超过1种物质的高危使用。

临床怎么用

  • 支持对择期手术患者进行普遍术前物质使用筛查,以识别围术期不良结局高风险患者并实施针对性风险缓解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Substance use is a modifiable risk factor that may adversely affect surgical outcomes, yet its prevalence using surgical risk-specific thresholds remains incompletely characterized in preoperative populations. STUDY DESIGN: We performed a cross-sectional analysis of preoperative screening data from a clinical trial (NCT05783635) at a large Midwestern health system. Between February 2024 and February 2025, 2,688 adults 21 to 75 years of age undergoing elective surgery completed validated self-report assessments of alcohol, nicotine, cannabis, and other drug use. High-risk use was defined as Alcohol Use Disorders Identification Test-Consumption scores ≥5 or weekly or daily use of other substances. Polysubstance use was defined as high-risk use of more than 1 substance. Multivariable logistic regression evaluated associations between patient and surgical factors and high-risk use. RESULTS: Overall, 27.6% (743) of patients reported high-risk substance use and 6.6% (177) reported polysubstance use. Cannabis was the most prevalent high-risk substance (15.0%), followed by alcohol (11.1%), nicotine (8.5%), and other drugs (0.4%). Younger age, male sex, and poorer self-reported health were associated with increased odds of high-risk use. Prevalence varied across surgical services, with the highest rates in neurosurgery (27.1% high risk and 11.4% polysubstance) and lowest in endocrine surgery (15.1% and 3.3%). CONCLUSIONS: More than 1 in 4 elective surgical patients report high-risk substance use before surgery. These findings support universal preoperative substance use screening to identify patients at elevated risk for adverse perioperative outcomes and enable targeted risk mitigation.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Ju X, Mueller-Williams AC, Kocher A, et al. High-Risk Substance and Polysubstance Use Among Elective Surgery Patients: Prevalence and Risk Factors. J Am Coll Surg. 2026. PMID: 42065385. doi:10.1097/XCS.0000000000001991

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。